MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Correlation of Phonation With Deglutition and Aspiration Risk in the ICU Patients - an Exploratory Study

Not Applicable

Completed

Conditions: Aspiration

Interventions: Other: Combined speech therapy tools, measures of swallowing function

First Posted Date: 2009-11-11

Last Posted Date: 2013-07-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT01011803

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia

Phase 1

Terminated

Conditions: Recurrent Chronic Lymphocytic Leukemia

Interventions: Drug: Lenalidomide
Drug: R-(-)-Gossypol Acetic Acid
Other: Laboratory Biomarker Analysis

First Posted Date: 2009-10-29

Last Posted Date: 2020-06-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 5

Registration Number: NCT01003769

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Behavioral Trial Studying Programmed Training to Improve Advocacy Skills for Individuals With Traumatic Brain Injury

Phase 2

Completed

Conditions: Brain Injuries

Interventions: Behavioral: Advocacy training curriculum
Behavioral: Self-directed

First Posted Date: 2009-10-27

Last Posted Date: 2013-01-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 234

Registration Number: NCT01002677

Locations: 🇺🇸
Brain Injury Association of Wisconsin, Pewaukee, Wisconsin, United States
🇺🇸
Brain Injury Association of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Brain Injury Association of Iowa, Urbandale, Iowa, United States

Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes

Not Applicable

Completed

Conditions: Hot Flashes

Interventions: Drug: placebo
Drug: venlafaxine
Procedure: mind-body intervention procedure
Procedure: hypnotherapy

First Posted Date: 2009-10-23

Last Posted Date: 2025-01-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 71

Registration Number: NCT01000623

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Registry for Study of Coils in Intracranial Aneurysms

Completed

Conditions: Cerebral Aneurysms

First Posted Date: 2009-10-23

Last Posted Date: 2019-06-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 114

Registration Number: NCT01000675

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

Phase 3

Terminated

Conditions: Recurrent Breast Carcinoma
Neuropathy
Pain
Stage IV Breast Cancer

Interventions: Drug: Calcium Gluconate
Other: Placebo
Drug: Magnesium Sulfate
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Drug: Ixabepilone

First Posted Date: 2009-10-20

Last Posted Date: 2016-02-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT00998738

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant

Phase 2

Completed

Conditions: Stage II Multiple Myeloma
Stage III Multiple Myeloma
Multiple Myeloma
Stage I Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Drug: plerixafor
Drug: filgrastim

First Posted Date: 2009-10-20

Last Posted Date: 2015-05-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT00998049

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Phase 4

Completed

Conditions: Symptomatic Uterine Leiomyomas
Myomas
Uterine Fibroids
Fibroids

Interventions: Procedure: Uterine artery embolization (UAE)
Procedure: Focused ultrasound (MRgFUS)

First Posted Date: 2009-10-15

Last Posted Date: 2018-01-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 56

Registration Number: NCT00995878

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Duke University Health System, Durham, North Carolina, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1

Withdrawn

Conditions: Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
Procedure: allogeneic bone marrow transplantation
Drug: bortezomib
Drug: melphalan
Drug: anti-thymocyte globulin
Drug: sirolimus
Drug: tacrolimus
Radiation: total-body irradiation

First Posted Date: 2009-10-14

Last Posted Date: 2023-01-05

Lead Sponsor: Mayo Clinic

Registration Number: NCT00995059

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2009-09-30

Last Posted Date: 2016-01-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8

Registration Number: NCT00987376

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy